Latest filing published 02 Jun 2026 for Phibro Animal Health CORP, €274k. Read the official filing
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
e. Thomas Corcoran (board member) discloses dealings in Phibro Animal Health Corp to SEC (Form 4). In total, 4 filings cover trades dated from 30 August 2021 to 29 May 2026.
On the market, this insider has only ever bought: 4 purchases, €570k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2026, the count stands at 1 purchase and no sales.
Half of the purchases are above €103k and half below. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.
Most recently, on 2 June 2026, the filings show an open-market purchase worth €274k in Phibro Animal Health Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations